Full-Time

Bioreactor Systems Lead

Posted on 12/20/2024

Retro Biosciences

Retro Biosciences

51-200 employees

Develops therapeutics targeting aging mechanisms

Biotechnology
Healthcare

Compensation Overview

$140k - $180kAnnually

Senior, Expert

San Carlos, CA, USA

Position requires onsite presence in Redwood City, CA.

Category
Bioinformatics
Biology Lab & Research
Biology & Biotech
Requirements
  • 8+ years of industry experience developing and scaling bioreactor systems for cell culture, preferably with iPSC-derived cells.
  • Proficient in automation technologies and process control systems used in bioreactor operations.
  • Worked under cGMP conditions and have some understanding of regulatory requirements (eg 21 CFR Part 11) for cell therapy manufacturing.
  • Working experience with closed manufacturing systems, tube welding, and aseptic connectors.
Responsibilities
  • Be a hands-on leader; lead a high-performing team and provide technical mentorship while also making significant contributions as an individual.
  • Ensure alignment between Retro's strategic goals and day-to-day execution of the team.
  • Develop and scale closed bioreactor systems for perfusion-based culture of iPSC-derived cells.
  • Transition prototype bioreactor designs into robust, production-ready systems suitable for cGMP manufacturing.
  • Optimize processes to enhance efficiency, reliability, and reproducibility of cell culture operations.
  • Ensure bioreactor systems and processes comply with regulatory requirements and standards for cGMP conditions.
  • Implement process control strategies and monitoring systems to maintain optimal cell culture environments.
  • Work cross-functionally with research and process development to integrate bioreactor systems into existing workflows.
  • Troubleshoot and resolve technical issues related to bioreactor operations and automation.
  • Document processes, protocols, and system designs to support regulatory submissions and internal knowledge sharing.
  • Implement new ideas and integrate modifications to existing bioreactors/processes to achieve the desired results.

Retro Biosciences focuses on extending healthy human lifespan by ten years through the development of therapeutics that target the cellular mechanisms of aging. The company addresses the root causes of age-related diseases, which are responsible for a significant portion of healthcare costs. Its product development is organized into three main programs: cellular reprogramming, plasma-inspired therapeutics, and autophagy, each at different stages of progress. Retro Biosciences utilizes advanced technologies like single-cell multi-omics and computational biology to enhance its research and development efforts. Unlike many competitors, Retro Biosciences aims to prevent multiple diseases by focusing on aging itself rather than treating individual conditions. The company's goal is to reduce healthcare expenses associated with age-related diseases while improving the quality of life for individuals as they age.

Company Stage

Seed

Total Funding

$175.1M

Headquarters

Redwood City, California

Founded

2021

Growth & Insights
Headcount

6 month growth

7%

1 year growth

29%

2 year growth

165%
Simplify Jobs

Simplify's Take

What believers are saying

  • Retro Biosciences secured $180 million funding, supporting operations and research for a decade.
  • Partnership with Multiply Labs enhances cost-efficient, scalable cell therapy manufacturing.
  • Increased interest in longevity research drives more funding and partnerships in biotech.

What critics are saying

  • Regulatory scrutiny on anti-aging therapies could delay clinical trials and approvals.
  • New competitors like Altos Labs could impact Retro Biosciences' market share.
  • Reliance on Multiply Labs' systems poses risks if technological failures occur.

What makes Retro Biosciences unique

  • Retro Biosciences targets cellular mechanisms of aging to extend lifespan by ten years.
  • The company employs a diversified model with cellular reprogramming, plasma therapy, and autophagy.
  • Retro Biosciences leverages advanced technologies like single-cell multi-omics and computational biology.

Help us improve and share your feedback! Did you find this helpful?